Table 2.

The distribution of basophils (%) in blood at baseline and after 12 weeks of supplementation with Cr, Cu or both Cr and Cu^*

	Basophils
Group†	Baseline	12 weeks	Change‡
− Cr −Cu	1·1 ± 0·1	0·9 ± 0·1	− 0·2 ± 0·1
+ Cr −Cu	1·0 ± 0·1	0·9 ± 0·1	− 0·1 ± 0·1
− Cr +Cu	0·8 ± 0·2	1·1 ± 0·1	0·2 ± 0·1
+ Cr +Cu	1·0 ± 0·1	1·1 ± 0·2	0·1 ± 0·2
− Cr	0·9 ± 0·1	1·0 ± 0·1	0·1 ± 0·1
+ Cr	1·0 ± 0·1	1·0 ± 0·1	0·0 ± 0·1
− Cu	1·0 ± 0·1	0·9 ± 0·1	− 0·1 ± 0·1
+ Cu	0·9 ± 0·1	1·1 ± 0·1	0·2 ± 0·1

Factors	P-values
Cr	0·74	1·00	0·92
Cu	0·23	0·10	x003C; 0·003
Cr × Cu	0·34	1·00	0·45

^*Values are mean ± s.e.m., n = 6–8.

^†See Table 1 for description of groups.

^‡Change, difference in values between baseline and the end of the study (after 12 weeks of supplementation).